...
首页> 外文期刊>International Journal of Medical Sciences >Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer's disease
【24h】

Vasculotide restores the blood-brain barrier after focused ultrasound-induced permeability in a mouse model of Alzheimer's disease

机译:血管素在聚焦超声诱导的阿尔茨海默病疾病模型中恢复血脑屏障后恢复血脑屏障

获取原文
           

摘要

Focused ultrasound (FUS) is used to locally and transiently induce blood-brain barrier (BBB) permeability, allowing targeted drug delivery to the brain. The purpose of the current study is to evaluate the potential of Vasculotide to accelerate the recovery of the BBB following FUS disruption in the TgCRND8 mouse model of amyloidosis, characteristic of Alzheimer's disease (AD). Accelerating the restoration of the BBB post-FUS would represent an additional safety procedure, which could be beneficial for clinical applications. Methods: TgCRND8 mice and their non-transgenic littermates were treated with Vasculotide (250 ng, intraperitoneal) every 48 hours for 3 months. BBB permeability was induced using FUS, in presence of intravenously injected microbubbles, in TgCRND8 and non-transgenic mice, and confirmed at time 0 by MRI enhancement using the contrast agent gadolinium. BBB closure was assessed at 6, 12 and 20 hours by MRI. In a separate cohort of animals, BBB closure was assessed at 24-hours post-FUS using Evans blue injected intravenously and followed by histological evaluation. Results: Chronic Vasculotide administration significantly reduces the ultra-harmonic threshold required for FUS-induced BBB permeability in the TgCRND8 mice. In addition, Vasculotide treatment led to a faster restoration of the BBB following FUS in TgCRND8 mice. BBB closure after FUS is not significantly different between TgCRND8 and non-transgenic mice. BBB permeability was assessed by gadolinium up to 20-hours post-FUS, demonstrating 87% closure in Vasculotide treated TgCRND8 mice, as opposed to 52% in PBS treated TgCRND8 mice, 58% in PBS treated non-transgenic mice, and 74% in Vasculotide treated non-transgenic mice. In both TgCRND8 mice and non-transgenic littermates the BBB was impermeable to Evans blue dye at 24-hours post-FUS. Conclusion: Vasculotide reduces the pressure required for microbubble ultra-harmonic onset for FUS-induced BBB permeability and it accelerates BBB restoration in a mouse model of amyloidosis, suggesting its potential clinical utility to promote vascular health, plasticity and repair in AD.? The author(s).
机译:聚焦超声(FUS)用于局部和瞬时诱导血脑屏障(BBB)渗透性,使靶向药物输送到脑中。目前研究的目的是评估血管芸苔的潜力,以加速淀粉样蛋白病的TGCRND8小鼠模型中的FUS中断后BBB的复苏,阿尔茨海默病(AD)的特征。加速BBB后保险丝的恢复将代表额外的安全程序,这可能对临床应用有益。方法:每48小时用血管素(250 ng,腹膜内)治疗TGCRND8小鼠及其非转基因凋落物3个月。使用FUS,在TGCRND8和非转基因小鼠中,在静脉内注射微泡的情况下使用FU来诱导BBB渗透性,并通过使用造影剂Gadolinium在MRI增强的时间0来证实。 BBB封闭在MRI的6,12和20小时评估。在单独的动物队列中,使用静脉注射的Evans蓝色,然后进行组织学评估,在24小时后,在保险丝后24小时评估BBB闭合。结果:慢性血管晶醛管理局部显着降低了在TGCRND8小鼠中诱导的FUS诱导的BBB渗透所需的超谐波阈值。此外,血管素治疗导致在TGCRND8小鼠中的FUS追踪BBB的速度更快。在TGCRND8和非转基因小鼠之间没有显着不同的BBB闭合。 BBB渗透率由钆渗透率,高达20小时的保险丝后,在血管恒温处理的TGCRND8小鼠中展示了87%的闭合,而不是PBS处理的TGCRND8小鼠52%,PBS处理的非转基因小鼠58%,74%血管素治疗非转基因小鼠。在TGCRND8小鼠和非转基因凋落物中,BBB在FUS后24小时内不可渗透到埃文斯蓝染料。结论:血管素减少了微泡超谐波发作所需的压力,用于保险诱导的BBB渗透性,并加速BBB恢复在淀粉样蛋白症的小鼠模型中,表明其促进广告中血管健康,可塑性和修复的潜在临床效用。作者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号